ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

14-day daily pre-operative application of the formulations containing MLYAAT-1002® before Fotona4D treatment

A development code. Also written as “Fractional picosecond laser treatment followed by daily use of formulations containing MLYAAT-1002®.” and “Fotona4D Pro® treatment followed by daily use of formulations containing MLYAAT-1002®”.

Its studies are mostly in Skin Manifestations · Skin Diseases, led by Botanee Group.

Furthest: no phase, since Oct 31, 20233 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Botanee Group31 open or runningno phasesince Oct 31, 2023Oct 31, 2023none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 31, 2023First study: no phase study in Cutis LaxaFirst studyNCT06140628 · 37 enrolled · China
  2. Dec 6, 2023No phase study in Skin ManifestationsNCT06188338 · 24 enrolled · China
  3. Mar 18, 2025No phase study in Skin DiseasesNCT06891924 · 33 planned

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06891924Skin Diseases–Not yet recruitingJun 1, 202533
NCT06188338Skin Manifestations · China–CompletedJan 27, 202424
NCT06140628Cutis Laxa · China–CompletedNov 7, 202337

How it is read

Names in the registry

  • “14-day daily pre-operative application of the formulations containing MLYAAT-1002® before Fotona4D treatment”, 1 entry
  • “Fractional picosecond laser treatment followed by daily use of formulations containing MLYAAT-1002®.”, 1 entry
  • “Fotona4D Pro® treatment followed by daily use of formulations containing MLYAAT-1002®”, 1 entry

Codes read as this program: MLYAAT1002.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.